@CNBCnow @megtirrell $1.24b in sales for Ibrance q1 vs ‘new Pfizer’ (Biopharma) revs of $10b ($12b inc Upjohn)

It’s a legit concern.

I’m still #bullish on $PFE

But wowza, Biopharma exciting as always... and I hope that the stakeholders, I hope there is a solid plan to take care of them (patients).